UCB - Current Liabilities

Stock Price
249.60
Daily Change
-3.00 -1.19%
Monthly
-11.08%
Yearly
38.78%
Q1 Forecast
243.41

UCB reported EUR3.53B in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Alcon AG USD 3.05B 59M Dec/2025
Almirall EUR 350.64M 52.12M Dec/2025
Amarin USD 182.23M 3.71M Sep/2025
argenx SE USD 1.04B 371.99M Jun/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
Galapagos EUR 152.86M 213.7M Dec/2025
Genmab DKK 629M 127M Jun/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
GRIFOLS EUR 2.02B 135.85M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 9.04B 405M Dec/2025
Novartis USD 32B 286M Sep/2025
Orion EUR 560.3M 9.8M Dec/2025
Recordati EUR 1.04B 24.44M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
UCB EUR 3.53B 731M Dec/2024
Unibail Rodamco EUR 5.17B 181.4M Dec/2024